Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Seattle Genetics `Guided Missile' Drug Blasts Rare Lymphoma in New Study
Bloomberg
Tuesday, December 7, 2010 - 12:07pm
tags:
Seattle Genetics, lymphoma, Takeda
Japan's Astellas Pharma investing $10M in Cytori
Yahoo/AP
Tuesday, December 7, 2010 - 12:05pm
tags:
Astellas, Cytori
PhRMA quickly names Chris Viehbacher as new leader following Kindler resignation
The Hill
Tuesday, December 7, 2010 - 11:58am
tags:
Chris Viehbacher, PhRMA, Jeff Kindler, Sanofi
Johnson & Johnson faces thousands of suits over its antibiotic Levaquin.
Minneapolis Star Tribune, MN
Tuesday, December 7, 2010 - 11:45am
tags:
JNJ, lawsuits, antibiotics, Levaquin
Analyst upgrades 2 Euro drugmakers, downgrades 1
Yahoo/AP
Tuesday, December 7, 2010 - 11:42am
tags:
Novartis, AstraZeneca, GSK
Merck Plans Bond Sale of Up to $2.5 Billion After S&P Boosts Credit Rating
Bloomberg
Tuesday, December 7, 2010 - 11:41am
tags:
Merck, bonds
GlaxoSmithKline to buy Chinese company for $70M
Bizjournals.com
Tuesday, December 7, 2010 - 11:40am
tags:
China, GSK, M&A, Nanjing MeiRui
Sanofi Said Unwilling to Meet Both Genzyme Demands
Bloomberg
Tuesday, December 7, 2010 - 8:03am
tags:
Genzyme, Sanofi, M&A
Geron plans to sell more stock; shares slip
Yahoo/AP
Tuesday, December 7, 2010 - 8:02am
tags:
Geron, stock offering
Orexigen Therapeutics: FDA Panel Live Blog
TheStreet.com
Tuesday, December 7, 2010 - 7:56am
tags:
FDA, advisory panels, Orexigen, Contrave, obesity
Pfizer’s Kindler Said to Leave After Jilting Read
Bloomberg
Tuesday, December 7, 2010 - 7:55am
tags:
Ian Read, Jeff Kindler, Pharma CEOs, Pfizer
Why the Street Should Love King Pharmaceuticals' Earnings
Motley Fool
Monday, December 6, 2010 - 7:30pm
tags:
earnings, King, Teva Pharmaceuticals, Endo, Elan
Spectrum's Zevalin shows positive results in study
Yahoo/AP
Monday, December 6, 2010 - 7:26pm
tags:
Zevalin, Spectrum Pharmaceuticals, follicular lymphoma
Orexigen braces for advisory panel's Contrave review
Fierce Biotech
Monday, December 6, 2010 - 5:04pm
tags:
Orexigen, Contrave, FDA, advisory panels, obesity
Read takes over a Pfizer facing many difficulties
Yahoo/AP
Monday, December 6, 2010 - 5:02pm
tags:
Pfizer, Jeff Kindler, Ian Read
Abbott Labs, The Stent Doc And A Pig Roast
Pharmalot
Monday, December 6, 2010 - 4:24pm
tags:
Abbott Laboratories, stents, physicians
Will Impax Laboratories Earn or Burn?
Motley Fool
Monday, December 6, 2010 - 4:21pm
tags:
Impax, Teva Pharmaceuticals, Pfizer, Elan
Pfizer Change of Guard Won't Make a Difference
Seeking Alpha
Monday, December 6, 2010 - 11:34am
tags:
Pfizer, Pharma CEOs, Ian Read, Jeff Kindler
Otsuka Sets Price for $2.4 Billion Tokyo IPO at the Lower End of Its Range
Bloomberg
Monday, December 6, 2010 - 11:30am
tags:
Otsuka, Japan, IPOs
Novartis: Tasigna surpasses Glivec in study
Fierce Pharma
Monday, December 6, 2010 - 11:23am
tags:
Tasigna, Glivec, Novartis, leukemia

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.